EIP
GILD icon

Ellis Investment Partners’s Gilead Sciences GILD Stock Holding History

Ellis Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-423
Closed -$26K – 404
2022
Q3 		$26K Buy
423
+4
+1% +$252 0.01% 457
2022
Q2 		$25K Sell
419
-195
-32% -$12.1K 0.01% 475
2022
Q1 		$36K Buy
614
+108
+21% +$6.9K 0.01% 452
2021
Q4 		$36K Buy
506
+123
+32% +$8.47K 0.01% 462
2021
Q3 		$26K Buy
383
+3
+0.8% +$211 0.01% 477
2021
Q2 		$26K Buy
380
+4
+1% +$267 0.01% 479
2021
Q1 		$24K Buy
376
+4
+1% +$258 0.01% 477
2020
Q4 		$22K Sell
372
-201
-35% -$12.1K 0.01% 467
2020
Q3 		$36K Buy
573
+6
+1% +$416 0.01% 406
2020
Q2 		$43K Sell
567
-577
-50% -$44.2K 0.02% 378
2020
Q1 		$82K Buy
1,144
+52
+5% +$3.59K 0.04% 224
2019
Q4 		$71K Sell
1,092
-577
-35% -$37.6K 0.02% 290
2019
Q3 		$105K Buy
1,669
+84
+5% +$5.49K 0.04% 221
2019
Q2 		$107K Buy
+1,585
New +$104K 0.04% 219

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ellis Investment Partners's GILD Position: Q4 2022 in Review

Ellis Investment Partners sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 423 shares — an estimated $26K sold.

Ellis Investment Partners first reported a position in GILD in Q2 2019 and held it in 14 quarters. The position peaked at $107K in Q2 2019. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Ellis Investment Partners reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 423 Gilead Sciences shares in Q4 2022, an estimated $26K.
  • Ellis Investment Partners first reported a position in Gilead Sciences in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's Gilead Sciences position peaked at $107K in Q2 2019.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.